Stocks and Investing
Stocks and Investing
Mon, October 11, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, October 10, 2021
[ 12:00 AM ] - WOPRAI
Fri, October 8, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Swayampakula Ramakanth Maintained (BCYC) at Strong Buy with Increased Target to $65 on, Oct 8th, 2021
Swayampakula Ramakanth of HC Wainwright & Co., Maintained "Bicycle Therapeutics plc" (BCYC) at Strong Buy with Increased Target from $39 to $65 on, Oct 8th, 2021.
Swayampakula has made no other calls on BCYC in the last 4 months.
There are 2 other peers that have a rating on BCYC. Out of the 2 peers that are also analyzing BCYC, 0 agree with Swayampakula's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Swayampakula
- Kalpit Patel of "B. Riley Securities" Initiated at Strong Buy and Held Target at $56 on, Thursday, September 30th, 2021
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Thursday, July 15th, 2021
Contributing Sources